Baker Bros. Advisors as of June 30, 2017
Portfolio Holdings for Baker Bros. Advisors
Baker Bros. Advisors holds 120 positions in its portfolio as reported in the June 2017 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Incyte Corporation (INCY) | 37.6 | $4.3B | 34M | 125.91 | |
Seattle Genetics | 20.7 | $2.4B | 46M | 51.74 | |
Alexion Pharmaceuticals | 9.1 | $1.0B | 8.6M | 121.67 | |
ACADIA Pharmaceuticals (ACAD) | 6.3 | $720M | 26M | 27.89 | |
BioMarin Pharmaceutical (BMRN) | 4.7 | $536M | 5.9M | 90.82 | |
Genomic Health | 3.9 | $449M | 14M | 32.55 | |
Dbv Technologies S A (DBVT) | 1.7 | $197M | 5.5M | 35.71 | |
Beigene (BGNE) | 1.4 | $165M | 3.7M | 45.00 | |
Aquinox Pharmaceuticals | 1.3 | $154M | 11M | 14.07 | |
Achaogen | 0.9 | $104M | 4.8M | 21.73 | |
Amarin Corporation (AMRN) | 0.8 | $91M | 23M | 4.03 | |
Advanced Accelerat spon ads each rep 2 ord | 0.8 | $87M | 2.2M | 39.04 | |
Spark Therapeutics | 0.7 | $79M | 1.3M | 59.74 | |
Invitae (NVTA) | 0.6 | $70M | 7.3M | 9.56 | |
BioCryst Pharmaceuticals (BCRX) | 0.6 | $65M | 12M | 5.56 | |
Bellicum Pharma | 0.5 | $59M | 5.0M | 11.68 | |
Exelixis (EXEL) | 0.5 | $51M | 2.1M | 24.63 | |
Avexis | 0.5 | $51M | 625k | 82.16 | |
Ascendis Pharma A S (ASND) | 0.4 | $49M | 1.8M | 27.76 | |
Novavax Inc note 3.750% 2/0 | 0.4 | $47M | 109M | 0.43 | |
Heron Therapeutics (HRTX) | 0.3 | $39M | 2.8M | 13.85 | |
Sangamo Biosciences (SGMO) | 0.3 | $36M | 4.1M | 8.80 | |
Bluebird Bio (BLUE) | 0.3 | $32M | 301k | 105.05 | |
Acorda Therap note 1.75% 6/15 | 0.3 | $30M | 35M | 0.85 | |
Neurocrine Biosciences (NBIX) | 0.2 | $28M | 617k | 46.00 | |
Versartis | 0.2 | $29M | 1.7M | 17.45 | |
Cerus Corporation (CERS) | 0.2 | $26M | 10M | 2.51 | |
Progenics Pharmaceuticals | 0.2 | $21M | 3.2M | 6.79 | |
ImmunoGen (IMGN) | 0.2 | $21M | 3.0M | 7.11 | |
Halozyme Therapeutics (HALO) | 0.2 | $20M | 1.6M | 12.82 | |
Galapagos Nv- (GLPG) | 0.2 | $20M | 260k | 76.52 | |
Xencor (XNCR) | 0.2 | $18M | 872k | 21.11 | |
Merus N V (MRUS) | 0.2 | $18M | 1.2M | 15.85 | |
Idera Pharmaceuticals | 0.1 | $18M | 10M | 1.72 | |
Sage Therapeutics (SAGE) | 0.1 | $17M | 208k | 79.64 | |
Neuroderm Ltd F | 0.1 | $17M | 572k | 29.90 | |
Intellia Therapeutics (NTLA) | 0.1 | $17M | 1.1M | 16.00 | |
Aerie Pharmaceuticals | 0.1 | $16M | 299k | 52.55 | |
La Jolla Pharmaceuticl Com Par | 0.1 | $15M | 505k | 29.77 | |
Array BioPharma | 0.1 | $13M | 1.6M | 8.37 | |
Catalyst Pharmaceutical Partners (CPRX) | 0.1 | $14M | 5.1M | 2.76 | |
Biomarin Pharmaceutical Inc note 0.750%10/1 | 0.1 | $14M | 12M | 1.11 | |
Aimmune Therapeutics | 0.1 | $14M | 674k | 20.56 | |
Loxo Oncology | 0.1 | $11M | 138k | 80.19 | |
Foamix Pharmaceuticals | 0.1 | $11M | 2.5M | 4.64 | |
Aegerion Pharmaceuticals 2% Du cvbond | 0.1 | $12M | 15M | 0.80 | |
Abeona Therapeutics | 0.1 | $11M | 1.7M | 6.40 | |
Ligand Pharmaceuticals In (LGND) | 0.1 | $8.9M | 73k | 121.40 | |
Alkermes (ALKS) | 0.1 | $8.7M | 150k | 57.97 | |
Ignyta | 0.1 | $9.3M | 896k | 10.35 | |
Syros Pharmaceuticals | 0.1 | $9.2M | 575k | 16.09 | |
Achillion Pharmaceuticals | 0.1 | $8.5M | 1.9M | 4.59 | |
Mirati Therapeutics (MRTX) | 0.1 | $8.3M | 2.3M | 3.65 | |
Intra Cellular Therapies (ITCI) | 0.1 | $7.6M | 609k | 12.42 | |
Cymabay Therapeutics (CBAY) | 0.1 | $7.4M | 1.3M | 5.76 | |
Rigel Pharmaceuticals (RIGL) | 0.1 | $6.9M | 2.5M | 2.73 | |
Insmed (INSM) | 0.1 | $6.9M | 400k | 17.16 | |
Agios Pharmaceuticals (AGIO) | 0.1 | $6.6M | 129k | 51.45 | |
Macrogenics (MGNX) | 0.1 | $6.4M | 364k | 17.51 | |
D Stemline Therapeutics | 0.1 | $5.8M | 634k | 9.20 | |
Glycomimetics (GLYC) | 0.1 | $6.3M | 563k | 11.16 | |
Assembly Biosciences (ASMB) | 0.1 | $5.2M | 250k | 20.65 | |
Contrafect | 0.1 | $5.9M | 4.0M | 1.45 | |
Selecta Biosciences (RNAC) | 0.1 | $5.8M | 290k | 19.86 | |
Array Biopharma Inc note 3.000% 6/0 | 0.0 | $4.1M | 3.0M | 1.36 | |
Aeglea Biotherapeutics | 0.0 | $4.4M | 1.1M | 3.85 | |
Spring Bk Pharmaceuticals In | 0.0 | $5.1M | 373k | 13.54 | |
Albireo Pharma | 0.0 | $4.1M | 200k | 20.60 | |
Newlink Genetics Corporation | 0.0 | $3.7M | 500k | 7.35 | |
Epizyme | 0.0 | $3.5M | 233k | 15.10 | |
Adamas Pharmaceuticals | 0.0 | $3.0M | 173k | 17.49 | |
Inotek Pharmaceuticals 5.75% Cb 08/01/2021-registe bond | 0.0 | $3.0M | 5.0M | 0.60 | |
Ra Pharmaceuticals | 0.0 | $3.3M | 178k | 18.74 | |
Nabriva Therapeutics | 0.0 | $3.7M | 350k | 10.48 | |
Ovid Therapeutics (OVID) | 0.0 | $3.5M | 333k | 10.49 | |
Novavax | 0.0 | $2.3M | 2.0M | 1.15 | |
Karyopharm Therapeutics (KPTI) | 0.0 | $2.0M | 217k | 9.05 | |
Trevena | 0.0 | $2.2M | 950k | 2.30 | |
Alder Biopharmaceuticals | 0.0 | $2.5M | 217k | 11.45 | |
Protalix Biotherapeutics Inc note 4.500% 9/1 | 0.0 | $2.6M | 3.4M | 0.75 | |
Trillium Therapeutics, Inc. Cmn | 0.0 | $1.8M | 414k | 4.40 | |
Zogenix | 0.0 | $2.7M | 185k | 14.50 | |
Natera (NTRA) | 0.0 | $2.5M | 229k | 10.86 | |
Akari Therapeutics | 0.0 | $2.3M | 497k | 4.61 | |
Dimension Therapeutics | 0.0 | $1.8M | 1.3M | 1.45 | |
Sunesis Pharmaceuticals Inc Ne | 0.0 | $2.0M | 742k | 2.70 | |
Aevi Genomic | 0.0 | $2.2M | 1.6M | 1.33 | |
Tonix Pharmaceuticals Hldg C | 0.0 | $2.2M | 511k | 4.33 | |
Anaptysbio Inc Common (ANAB) | 0.0 | $2.8M | 117k | 23.93 | |
Argenx Se (ARGX) | 0.0 | $2.1M | 100k | 21.21 | |
Infinity Pharmaceuticals (INFIQ) | 0.0 | $911k | 580k | 1.57 | |
BioDelivery Sciences International | 0.0 | $588k | 210k | 2.80 | |
Palatin Technologies | 0.0 | $882k | 2.1M | 0.43 | |
Chimerix (CMRX) | 0.0 | $628k | 115k | 5.45 | |
Acceleron Pharma | 0.0 | $874k | 29k | 30.38 | |
Five Prime Therapeutics | 0.0 | $580k | 19k | 30.13 | |
Ultragenyx Pharmaceutical (RARE) | 0.0 | $1.6M | 25k | 62.12 | |
Mediwound Ltd cmn | 0.0 | $1.5M | 226k | 6.80 | |
Immune Design | 0.0 | $1.5M | 149k | 9.75 | |
Affimed Therapeutics B V (AFMD) | 0.0 | $820k | 400k | 2.05 | |
Dynavax Technologies (DVAX) | 0.0 | $724k | 75k | 9.65 | |
Juno Therapeutics | 0.0 | $1.5M | 50k | 29.90 | |
Cellectis S A (CLLS) | 0.0 | $1.3M | 50k | 25.82 | |
Invivo Therapeutics Hldgs | 0.0 | $1.1M | 400k | 2.70 | |
Seres Therapeutics (MCRB) | 0.0 | $1.4M | 125k | 11.30 | |
Corbus Pharmaceuticals Hldgs | 0.0 | $820k | 130k | 6.30 | |
Arbutus Biopharma (ABUS) | 0.0 | $650k | 181k | 3.60 | |
Myokardia | 0.0 | $1.3M | 100k | 13.10 | |
Madrigal Pharmaceuticals (MDGL) | 0.0 | $939k | 58k | 16.26 | |
Fulgent Genetics (FLGT) | 0.0 | $799k | 125k | 6.39 | |
Jounce Therapeutics | 0.0 | $1.4M | 100k | 14.03 | |
Cyclacel Pharmaceuticals Inc pfd conv ex 6% (CYCCP) | 0.0 | $82k | 13k | 6.19 | |
Chemocentryx | 0.0 | $459k | 49k | 9.36 | |
Tenax Therapeutics | 0.0 | $98k | 133k | 0.74 | |
Proteon Therapeutics | 0.0 | $454k | 299k | 1.52 | |
Biotime Inc wts oct 1 18 | 0.0 | $7.0k | 20k | 0.35 | |
Biopharmx | 0.0 | $287k | 599k | 0.48 | |
Adaptimmune Therapeutics (ADAP) | 0.0 | $449k | 100k | 4.49 | |
Ritter Pharmaceuticals | 0.0 | $220k | 400k | 0.55 | |
Bioverativ Inc Com equity | 0.0 | $496k | 8.2k | 60.13 |